Physician profile
Michael Christensen
NPI 1023239712
$2,852.61
in general payments reported to CMS, 2019-2025
12 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,197 · 2020: $96.83 · 2021: $229 · 2022: $529 · 2023: $694 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500 · Consulting Fee: $200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.44 |
| Consulting Fee | $200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $661.32 | 2019-2021 | |
| Alcon Vision LLC | $493.39 | 2019-2023 | Air Optix, Total30 |
| Coopervision INC. | $486.03 | 2019-2025 | Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $378.45 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $259.74 | 2022-2023 | Miebo, Infuse |
| Allergan, INC. | $112.39 | 2021 | |
| Glaukos Corporation | $110.28 | 2023 | |
| Apellis Pharmaceuticals, INC. | $101.39 | 2023 | Syfovre |
| Mallinckrodt Hospital Products INC. | $90.82 | 2022 | |
| Horizon Therapeutics Plc | $78.01 | 2022 | |
| Abbvie INC. | $66.73 | 2022 | |
| Carl Zeiss Meditec, INC. | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.